Asserting that there is no dearth of hospital beds in the national capital to treat COVID-19 patients, he said the Delhi government would deploy medical professionals at each private hospital to keep a tab on available beds.

Petitioner Avishek Goenka’s counsel argued before a bench of Justices Ashok Bhushan, M R Shah and V Ramasubramanian that private hospitals were charging exorbitantly to treat Covid-19 patients, almost 10 times of what government hospitals were billing and pleaded that the pandemic situation should not be exploited to fleece patients.

"The number of Covid-19 cases are constantly increasing and at some point of time in the near future, apart from existing hospitals, large number of temporary make-shift hospitals will have to be created in order to accommodate Covid-19 patients requiring admission, medical care and treatment,” the Centre’s affidavit said.

The pharmacovigilance programme also monitored the use of HCQ for highrisk healthcare workers in the counrty Prophylaxis refers to treatment given to prevent a disease. YK Gupta, who is also a member of ICMR, said HCQ, an anti-malarial drug, had even less toxicity than chloroquine.

India’s daily number of new Covid-19 cases crossed 9,000 for the first time when 9,651 fresh infections were reported on Thursday along with 270 fatalities, the joint-highest death toll from the virus in a single day. With infections rising steadily, India reported the world’s third highest number of new cases in a single day on Wednesday, when the country’s count of 8,723 cases was higher than Russia’s (8,536).

At a press conference in the WHO headquarters in Geneva, Director General Tedros Adhanom Ghebreyesus said: "On the basis of the available mortality data, the members of the committee recommended that there are no reasons to modify the trial protocol.

Earlier this week, Vijayabaskar had said the government had received complaints that hospitals were fleecing patients. Minutes after the state released the tariff norms, IMA state secretary Dr AK Ravikumar said the doctors association will make a representation for revision.

Fitbit Flow builds on standard resuscitator bags, like those used by paramedics, with sophisticated instruments, sensors, and alarms that work together to support automated compressions and patient monitoring.

"We have on boarded 6,000 doctors who can provide consultation to patients over online video. Patients will not need to download a separate app for accessing doctors. They will get a link from the doctor on Whatsapp or any other messaging platform that can be accessed in a browser," Nowfloats head of research, Nikhil Salkar told.

Results from the preliminary research involving 19 patients, which was backed by the United States National Institutes of Health, encouraged the British drugmaker to explore the drug's new use in a wider clinical trial announced in April.

India's top drug regulator Drugs Controller General of India (DGCI) on Friday allowed Sun Pharmaceutical to conduct clinical trial for the first phytopharmaceutical or plant-based drug AQCH to treat COVID-19 patients.

As on June 6, there were 785 active cases in Udupi, 448 in Kalaburagi, 407 in Yadgir and 320 in Raichur. Karnataka has recorded 5,213 cases, and of these, 3,184 are active. The rest of the patients have recovered.

“The (Covid-19) crisis has only enhanced the requirement for such an online programme,” said Das. Learners could create their own “portfolio” of courses from various institutes and in future, a bunch of such certificate courses may even be considered to lead to a degree.

Treatment for Covid-19 with the antimalarial drug hydroxychloroquine, either with or without the antibiotic azithromycin, offers no benefit for Covid-19 patients, according to a large observational study.​​ The research, published in the journal The Lancet, analysed data from nearly 15,000 patients with Covid-19 who received chloroquine or its analogue hydroxychloroquine, taken with or without the antibiotics.

When the blood reaches these curves, it makes changes to its fluid mechanics and interactions with the vessel wall. In a healthy person, these changes are in harmony with the tortuous microenvironment, but when diseased, these environments could lead to very complex flow conditions that activate proteins and cells that eventually lead to blood clots.